Lycia Therapeutics, Inc

Lycia Therapeutics, Inc

Lycia Therapeutics, Inc

Developing first-in-class therapeutics that degrade extracellular proteins to address difficult-to-treat diseases
Raised
$50M
Follow us
Latest funding
$50,000,000
Venture capital - 2020
Versant Ventures
Team Size
1–10
Employees
$50,000,000 Venture capital
FinSMEs

Lycia Therapeutics Raises $50M in Launch Funding